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Objectives: To investigate the prescription and dispensation of psychotropic medications through the analysis
of the prescriptions/notices kept at various institutions in two cities in the state of São Paulo.
Methods: The prescriptions kept at drugstores, magistral pharmacies, primary care settings and hospitals were
collected and analyzed in collaboration with the Sanitary Vigilance agencies in the year of 1999. The information
in the prescriptions/notices were typed and tabulated.
Results: A total of 108,215 prescriptions were processed, being 76,954 for benzodiazepines, 26,930 for anorexigenic
drugs, 3,540 for opiates and 788 for other drugs. The benzodiazepines most frequently prescribed were: diazepam
(31,644), bromazepam (16,911) and clonazepam (7,929). Among the anorexigenic drugs, diethylpropion (14,800)
and femproporex (10,942) were the most common. When compared to men, women were given more prescriptions,
mainly for anorexigenic drugs: the ratio was 10:1 in the prescriptions for diethylpropion and femproporex. The few
magistral pharmacies (n=6) handled even more prescriptions than did the drugstores (n=49). A number of errors
and inconsistencies were detected in the prescriptions analyzed.
Conclusions: The results confirm the occurrence of an irrational use of such medications and a series of inadequate
practices related to their prescription in Brazil. Therefore, they point out to the need of a comprehensive review
of the government’s control system of these substances.
Psychotropic drugs. Legislation, drug. Prescriptions, drug. Anti-anxiety agents, benzodiazepine. Analgesics,
opioid. Amphetamines. Drug and narcotic control. Health survey. Pharmacoepidemiology.
Objetivos: Analisar a prescrição e dispensação de medicamentos psicotrópicos por meio da análise das receitas/
notificações retidas em diferentes estabelecimentos de dois municípios do estado de São Paulo.
Métodos: Em parceria com as Vigilâncias Sanitárias dos municípios, foram coletadas e analisadas as prescrições
retidas em drogarias, farmácias de manipulação, postos públicos e hospitais no ano de 1999. Os dados contidos
nas receitas/notificações foram digitados e tabulados.
Resultados: Foram processadas 108.215 prescrições, sendo 76.954 de benzodiazepínicos, 26.930 de anorexígenos,
3.540 de opiáceos e 788 de outros. Os benzodiazepínicos mais freqüentes foram: diazepam (31.644), bromazepam
(16.911) e clonazepam (7.929) e, entre os anorexígenos, dietilpropiona (14.800) e femproporex (10.942). As mulheres,
em geral, receberam mais prescrições em comparação com os homens, especialmente para os anorexígenos, com
uma relação dez vezes maior nas prescrições de dietilpropiona e femproporex. As poucas farmácias de manipulação
(n=6) chegaram a movimentar mais prescrições do que as drogarias (n=49). Também foi detectada uma série de
erros e incoerências nas prescrições analisadas.
Conclusões: Os resultados confirmam a ocorrência de uso irracional e uma série de práticas inadequadas que
envolvem a prescrição desses medicamentos no Brasil e, portanto, indicam a necessidade de uma ampla revisão
no atual sistema de controle dessas substâncias no país.
Psicotrópicos. Legislação de medicamentos. Prescrição de medicamentos. Agentes ansiolíticos benzodiazepínicos.
Analgésicos opióides. Anfetaminas. Controle de medicamentos e entorpecentes. Levantamentos epidemiológicos.
Farmacoepidemiologia.
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Introduction
According to the World Health Organization, ‘although most
of the industrialized countries control the selling and produc-
tion of benzodiapines, many developing countries do not have
enough control over these drugs.’1
The WHO has plenty of reason, at least as concerns Brazil. In
the past decade some papers pointed to a serious situation. For
example, in Belo Horizonte the use of anti-anxiety/hypnotic
agents by the elderly reached an astonishing figure of 95% of
respondents;2 in a small town with 10,000 inhabitants in the
State of São Paulo, 50% of them would be taking benzodiaz-
epines (according to the newspaper Folha de São Paulo 16/11/
94). In the years 1988 and 1989 the Brazilian consumption of
benzodiazepines was around 20 DDDs (Defined Daily Doses),
similar to the daily consumption in the US.3 In 1992, benzodiaz-
epines were the main cause of poisoning in children aging up to
12 in São Paulo.4
The excessive and unadvised use of benzodiazepines is
present in several other countries, such as Italy, Sweden, Bel-
gium and Chile among others.5-8
Some studies have also suggested the irrational and widely
spread use of amphetamine like stimulants as appetite reduc-
ers. The INCB (International Narcotics Control Board)9 in its
report of the year 1998, considers the use of anorexigenic drugs
as one of the main concerns in South America, and Brazil, Ar-
gentina and Chile are the most affected countries. Accordingly,
this international board recommends the adoption of legisla-
tive and administrative measures to face up the problem.9 Bra-
zilian studies have showed a yearly growth especially as re-
ceipts dispensed in Magistral Pharmacies.10 A study in the cit-
ies of São Paulo and Recife showed also the carelessness with
which physicians prescribe these anorexigenic agents associ-
ated to benzodiazepines.11,12 A recent revision about the widely
spread use of drugs such as amphetamines and its consequences
shows how serious is this problem in Brazil.13
On the other hand, the exaggerated consumption is not the
only noteworthy aspect; the WHO has indicated that the opi-
ate analgesics are insufficiently prescribed, particularly in de-
veloping countries. In 1991 Latin America consumed 1% of the
morphine world-widely used for therapeutic purposes.14 The
Brazilian consumption of opiates for analgesic purposes reached
in 1990 and 1991 202.86 and 207.75 DDDs/million of inhabit-
ants/day respectively. These figures mean that at least theo-
retically, only about 30,000 persons take 1 daily dose of an
opiate; an insignificant number compared to Brazil’s 1 million
cancer cases.15
These data show that this issue deserves more attention and
the first measure to be adopted in such cases is always to diag-
nose the situation. One classical example occurred in Malmo,
Sweden, which had the highest rate of prescriptions of benzo-
diazepines and other hypnotic agents;6 one study showed that
a small percentage (2.4%) of physicians of private settings were
responsible for a large percentage (24%) of all receipts. This
finding allowed the adoption of corrective measures what led
to a significant decrease in these receipts. We should mention
also that suicide attempts with these drugs (mainly barbitu-
rates) have also decreased in Malmo.6
The prescription and selling of drugs based on narcotic or
psychotropic substances in Brazil is regulated by the govern-
ment regulation number 344/98,16 which demands a Receipt No-
tice, a document that together with the receipt authorizes the
dispensation. The notices are kept in the institutions for inspec-
tion and control and may be used as a valuable information source
about the current practice of prescription/dispensation of psy-
choactive and psychotropic substances and medications.
Objectives
In order to contribute to a better understanding of the Brazil-
ian situation about the prescription and dispensation of nar-
cotic and psychotropic medications, the current study aimed to
analyze notices kept in drugstores, pharmacies, primary care
settings, hospitals, among others, in two cities of the state of
São Paulo in a year time (1999).
Methods
Sample
We analyzed the notices of narcotic and psychotropic medi-
cations (Lists “A” and “B” of the government regulation 344/
98),16 kept in the year 1999, in drugstores, magistral pharmacies,
primary care settings and public hospitals in two cities (450,000
inhabitants) in the state of São Paulo.*
Although the government regulation 344/9816 determined the
notice as the standard, it contemplates some exceptions such
as inpatients for which the prescription in non-controlled re-
ceipts is allowed. These receipts have also been analyzed in
our study.
Data collection
In order to enable the collection of prescriptions, it was
necessary to collaborate with the local Sanitary Vigilance
agencies and, therefore, the cities’ authorities were respon-
sible for the collection.
Although the government regulation 344/9816 determined that
these documents should be inspected some institutions ini-
tially resisted making them available. Due to the difficulties
found the collecting process was divided into stages, starting
with the public sources of dispensation (Primary Care Settings
and Public Hospitals), followed by drugstores and thirdly by
magistral pharmacies. The private hospitals were supposed to
be the fourth and last stage which was not performed due to
operational difficulties.
Organization of the material
The material received was organized in the Cebrid by a staff
responsible for verifying, quantifying, labeling and storing it.
During this process we found difficulties, such as the number
of documents (well above what was expected) the disorganiza-
tion of the material (especially those originated from public
sources) and the low quality of the professionals’ handwriting.
*We must highlight the fact that other cities were also invited to participate in the study, but only two of them were interested in. They belong to the Great São Paulo.
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Data processing and validation
The following fields were processed: general information
(state, series and official number of the notice, city and issuing
date of the notice); information about the issuing agency and
the physician in charge (CGC – General Taxpayers’ Register –
of the issuing agency, name of physician), CRM (Conselho
Regional de Medicina – state council responsible for accredit-
ing physicians and for the surveillance of medical practices)
and medical specialization; patient’s information (name, address
and gender); buyer’s information (name, ID number and ad-
dress); information about the drug (name, concentration, quan-
tity and presentation); supplier identification and dispensation
date. Besides these fields, two others were added: the medical
specialization (determined from a list of registered physicians
in the CRM/São Paulo) and the patient’s gender (inferred from
the patient’s name). For that purposes a program was devel-
oped in Delphi with a SQL Server 7.0 database.
In order to assure the quality of the processed data, the pro-
gram blocked and/or highlighted the incoherent data entered.
Collaboration with the CRM enable us to create the field ‘medi-
cal specialization’, which although was not in the notice could
be filled in after checking the CRM’s list of professionals.
Results and Discussion
The Sanitary Vigilance and the institutions
Table 1 presents the number of institutions (existent x sur-
veyed) responsible for the dispensation of medications included
in Lists ‘A’ and/or ‘B’ of the government regulation 344/98.16
Almost all dispensation sources of the two cities were ana-
lyzed, except for two magistral pharmacies that refused to par-
ticipate and the private hospitals.
This extensive participation was only possible after uncount-
able efforts performed by the local Sanitary Vigilance agency
which, despite having the legal right to demand the presenta-
tion of prescriptions, chose to call for a voluntary participation.
The lack human and financial resources in the Sanitary Vigi-
lance agencies, besides some political disagreements, also rep-
resented hindrances for the collection the documents.
Although the government regulation 344/9816 was elaborated
aiming to control the dispensation of psychotropics, the opera-
tional difficulties found along the current study demonstrate
the frailty of the public service to perform a true ‘surveillance’
regarding psychotropic medications.
General aspects of notices and receipts
We analyzed 108,212 prescriptions, which, during the year
1999, had been kept in the cities’ public and private institutions
(Table 1). Of these, 104,664 (96.7%) referred to drugs and sub-
stances included in List ‘B’ of the government regulation 344/
9816 and the remaining in List ‘A’ (3.3%).
Regarding the type of institutions 73.1% of the prescriptions
analyzed had been dispensed through private sources. The
number of documents dispensed in the only six magistral phar-
macies was higher than in the 49 drugstores, demonstrating the
significant participation of this type of institution in the dis-
pensation of prescribed drugs. The greatest figure observed
was in a magistral pharmacy that processed in 1999 19,792 no-
tices (about 80 notices per working day).
List ‘B’ notices were dominant in pharmacies and drugstores,
whereas all List ‘A’ medications were dispensed by hospitals,
totaling 3,548 documents.
As inpatients are allowed to receive prescriptions in non-
controlled receipts, all documents originated in hospitals (to-
taling 17,580 documents) were of this kind. Although this
amendment in the Government Regulation minimizes bureau-
cratic procedures and consequently facilitates the use of
psychotropics in hospital settings, on the other hand it may
also provide loopholes to deviate drugs. In this sense, it is
essential to analyze in detail the possible consequences of
this common practice.
Incoherent and wrong filling of notices
The low quality in the filling in of the notices was one the
most striking results in the current study.
Besides the low quality in the handwriting, that in itself would
deserve several considerations about how to fill in the docu-
ments, there were also lack of coherency and errors made both
by physicians and institutions.
The most common errors were related to not filling in certain
fields (“blank data”). Some documents even had only the
patient’s name filled in (all other fields were empty, including
those referred to the physician and prescribed drug).
The lack of information about the patient’s address was
the most common error and this information was absent in
42.3% of the notices, followed by the dispensation date
(24.5%), absence of state (13.1%, especially in pharmacies
and drugstores) and the identification of the ‘buyer’ (7.1%,
mainly in primary care settings).
Table 1 - Number of institutions responsible for the dispensation and number of notices or receipts related to the medications and substances of Lists
‘A’ and ‘B’ of the Government Regulation 344/98. Data separately presented according to the nature of the dispensation source of the two cities.
Number of institutions Total number of analyzed documents
Sources Existent Analyzed List A List B
Private
Magistral pharmacies 8 6 - 40,741
Drugstores* 49 49 - 38,372
Hospitals 6 0 - -
Public
Primary care settings 2 2 - 7,971
Hospitals (emergency care eettings) 2 2 781 9,969
Hospitals (hospitalization) 1 1 2,767 7,611
Total 68 60 3,548 104,664
*Drugstores that in the year 1999 were not contemplated did not dispensed drugs of Lists ‘A’ or ‘B’ of the Government Regulation 344/98.
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Other blank fields in many documents, both in notices and
non-controlled receipts, were the issuing date (9.7%) and the
drug concentration (6.6%, especially in hospitals).
There were a small number of incoherencies of dates and,
mainly in drugstores, erasures in the quantity (49 cases) and
concentration (17 cases) of the dispensed drugs.
There were also cases of documents which had repeated of-
ficial numbering, and even cases where the same official num-
bering was repeated in nine notices, what may suggest frauds.
The study’s impact in the rate of errors
A noteworthy phenomenon was the impact of the current
study in the rate of errors to fill in the documents. We may
mention that the data collecting process started in the public
institutions, more specifically in a mental health outpatient clinic
of one of the cities. In the first months of the research we started
preliminary analyses of the data, and several filling errors were
observed in that institution. This result was informed to the
professionals in charge of filling in the documents, and they
voluntarily corrected the procedures. Thus, we verified a sig-
nificant decrease in the filling errors. For instance, the rate of
absence of information about supplier and dispensation date
that reached 100% in the months of January and February, fell
subsequently to only 4.6% (in March) and 5.2% (in April).
This phenomenon shows that the analysis of these docu-
ments represents in itself a preventive measure to improve the
quality of handling them.
Prescribed drugs
Table 2 shows the number of analyzed documents, organized
separately according to the medications substance class.
List ‘A’ medications and substances
List ‘A’ medications and substances were exclusively dis-
pensed in hospitals and mostly to inpatients (77.8%). Among
the substances contained in this List, the most frequent was
meperidine (especially under the trade name of Dolantina),
totaling 2,038 documents. From the total of dispensed drugs in
hospital settings, meperidine represented 46.6% of opiates used
in inpatients and 96.6% of cases in Emergency Care settings.
On the other hand, we observed only 3 documents which dis-
pensed morphine (Dimorf), all of them used in the Emergency
care setting and, therefore, none of them for inpatients. This
information indicates the underprescription of this substance
what, according to the scientific literature, apparently originates
from a real ‘opiophobia’, i.e., a wrong medical approach based
on excessive fears of prescribing morphine. Although psycho-
tropic abuse is the most highlighted trend in the literature, the
cases of underprescription are also severe, since they deprive
patients from an adequate treatment.17
Regarding the profile of patients to whom List ‘A’ medica-
tions were dispensed, there was a distribution of about 1:1 be-
tween men and women (Figure).
Tabela 2 - Number of prescriptions of each therapeutic class of medications and substances of lists ‘A’ and ‘B’ of the Government Regulation 344/98. Data
displayed according to the nature of the dispensation source of the two cities.
Therapeutic class Institutions
Private Public Total
Magistral Drugstores Primary care Hospitals
pharmacies settings Emergency Hospitalization
care settings
Benzodiazepines 15,159 36,389 7,944 9,968 7,494 76,954
Non barbiturate hypnotic* 0 375 0 0 0 375
Barbiturate hypnotic 0 0 0 0 111 111
Antiparkinsonian 0 145 0 0 0 145
Anorexigenic 25,489 1,438 0 1 2 26,930
Opiates and opioid 0 0 0 781 2,759 3,540
Illegible 92 20 27 0 2 144
Blank 1 5 0 0 10 16
Total 40,741 38,372 7,971 10,750 10,378 108,215
*zolpidem and zopiclone.
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Figure 1 – Most frequently prescribed/dispensed psychotropics in the two
analyzed cities. Data separately presented according to the lists of the
Government Regulation 344/98 and according to the gender of patients who
received the prescription. Amounts are expressed in number of prescriptions.
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List ‘B’ medications and substances
Benzodiazepines were preponderantly dispensed in all
sources analyzed, except in magistral pharmacies (Table 2). Di-
azepam was the most frequent one, reaching almost 100% in
public primary care settings and hospitals. However, we must
stress the fact that the available medications in public institu-
tions were those included in a list standardized by the govern-
ment what reduces the possibility of other options.
On the other hand, when we analyzed the profile of drug-
stores and magistral pharmacies we could verify a quite differ-
ent picture, with a much more diversified range of benzodiaz-
epines. Bromazepam (especially Lexotan) followed by
clonazepam (Rivotril), lorazepam (especially Lorax),
alprazolam (Frontal), cloxazolam were predominant in drug-
stores, among others. However, in magistral pharmacies, be-
sides diazepam, the preparations with other benzodiazepines
were also frequent, especially bromazepan and chlordiazepoxide.
Regarding the patients’ gender (Figure), we observed a
clear-cut predominance of females for almost all benzodiaz-
epines. The female/male ratio was near 2/1 in one of the cit-
ies and 3/1 in the other. This ratio was even more dispropor-
tionate for bromazepam (4/1) and chlordiazepoxide (5/1), as
both are frequent in magistral pharmacies, usually associ-
ated to appetite suppressants which are consumed mostly
by females.
For List B2 of medications (appetite suppressants), 95.0% of
the documents were processed by magistral pharmacies, show-
ing that this is the major dispensation source of these sub-
stances. The most frequent psychotropics of this class were:
anphepramone (or diethylpropione), fenproporex (or
propionitrile) and, much less, mazindol.
Patients to whom were prescribed appetite suppressants were
mostly females, in a male/female ratio of 1/10 for amphepramone,
1/10 for fenproporex and 1/6 for mazindol.
Physicians in charge of the prescriptions
Most professionals (81.5%) issued less than 10 documents
during all the year, many of them only 1 document. On the other
hand, we observed that 13 professionals issued more than 1,000
documents/year.
Among the cases in which we detected overstatements, we
may mention a physician who issued 7,678 documents in 1999
(about 30-documents/working day), with almost all of them
(99%) being dispensed by the same magistral pharmacy. The
following physician with the greatest number of documents
issued 3,633 (about 14 receipts/working day) followed by an-
other with 2,075 (about 8/working day).
Most prescriptions were issued by general practitioners. For
the remaining, the most frequent specialty was psychiatry, fol-
lowed by labor medicine. However, for the latter we may say that
most of these prescriptions were issued by the same “labor phy-
sician” (the same previously mentioned, with 7,678), but who
probably was prescribing to reduce the appetite (considering the
great number of prescriptions of appetite suppressants). Other
medical specialties were also frequent, such as endocrinology,
gynecology, cardiology and neurology.
We observed 321 documents issued by physicians that were
not included in the CRM-SP list. These cases were checked
with this institution and notified to the Sanitary Vigilance agen-
cies. Among these, there were several physicians originated
from other states, some foreigners that had not a license to
practice the profession in the country, cases of physicians that
had been previously forbidden to work by the CRM and even
cases of physicians who had died several years before.
Patients
Despite the different possibilities of abbreviated writing of
the same name, we observed 225 patients’ names that were
repeated in more than twelve documents each, that is, a number
equivalent to more than one monthly notice. We must empha-
size that this figure does not include hospitalized patients, to
whom there would be a plausible reason for a greater number of
documents.
Considering that notices can refer at most to medications for
a 60-day treatment and that generally that was the quantity
observed in most of the analyzed documents (excluding hospi-
tal settings), we might expect that a single patient would re-
ceive up to 6 notices per year, or up to 12, considering a monthly
frequency or treatment using two psychotropics.
Several countries recommend that the treatment with appe-
tite suppressants must not overpass 3 months and, regarding
benzodiazepines, the WHO suggests that it must not overpass
4 weeks. Thus, the cases of patients with excessive prescrip-
tions must be assessed in detail in a second phase of the cur-
rent study, as many of them do not seem compatible with the
therapeutic purpose.
Buyers
The process to analyze buyers was simpler, as for the 78,468
documents that had their buyer field filled in, 68,834 (87.7%)
had the corresponding ID number. In that way, the information
could be analyzed not by its name but rather by its ID number.
We observed one case of 326 notices with the same ID card
number. However, when we analyzed the documents more in
detail we observed that, as a matter of fact, buyers’ (and pa-
tients’) names were different but all of them were dispensed in
the same drugstore.
Except for the mentioned case, the greatest number of pre-
scriptions under the same ID card number was 41, followed by
two cases with 40 and one with 36. As a whole, 18 buyers’ ID
card numbers had more than 24 documents each (equivalent to
more than 2 documents per month).
Conclusions
The results confirm the Brazilian trend to an irrational use of
narcotic and psychotropic medications. They also reveal sev-
eral inappropriate practices which involve the prescription and
dispensation of these drugs.
Consequently, the results suggest the need to reassess the
policies adopted to date regarding these substances in our coun-
try, but also indicate that it might be possible to change this
reality adopting relatively simple inspecting measures.
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